Increased susceptibility of diabetic mice to influenza virus infection: Compromise of collectin-mediated host defense of the lung by glucose?

Journal of Virology

Volumn 72, Issue 8, 1998, Pages 6884-6887

  Reading, Patrick C ^a   Allison, Janette ^b   Crouch, Erika C ^c   Margot Anders, E ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b ROYAL MELBOURNE HOSPITAL   (Australia)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; SURFACTANT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; HOST RESISTANCE; INFECTION SENSITIVITY; INFLUENZA VIRUS A; LUNG; MOUSE; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; TRANSGENIC MOUSE; VIROGENESIS; VIRUS INFECTION; VIRUS NEUTRALIZATION; VIRUS REPLICATION; VIRUS TITRATION;

EID: 0031947056     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.72.8.6884-6887.1998     Document Type: Article

References (21)

1. Allison, J., I. L. Campbell, T. E. Morahan, T. E. Mandel, L. C. Harrison, and J. F. A. P. Miller. 1988. Diabetes in transgenic mice resulting from overexpression of class I histocompatibility molecules in pancreatic β cells. Nature 333:529-533.
2. 2-microglobulin in transgenic mouse islet β cells results in defective insulin secretion. Proc. Natl. Acad. Sci. USA 88:2070-2074.
3. Anders, E. M., C. A. Hartley, and D. C. Jackson. 1990. Bovine and mouse serum β inhibitors of influenza A viruses are mannose-binding lectins. Proc. Natl. Acad. Sci. USA 87:4485-4489.
4. Bouter, K. P., R. J. A. Diepersloot, L. K. J. van Romunde, R. Uitslager, N. Masurel, J. B. L. Hoekstra, and D. W. Erkelens. 1991. Effect of epidemic influenza on ketoacidosis, pneumonia and death in diabetes mellitus: a hospital register survey of 1976-1979 in The Netherlands. Diabetes Res. Clin. Pract. 12:61-68.
5. Crouch, E. C., D. Chang, K. Rust, A. Persson, and J. Heuser. 1994. Recombinant pulmonary surfactant protein D. J. Biol. Chem. 269:15808-15813.
6. Diepersloot, R. J., K. P. Bouter, and J. B. Hoekstra. 1990. Influenza infection and diabetes mellitus. Case for annual vaccination. Diabetes Care 13:867-882.
7. Doherty, P. C., W. Allan, M. Eichelberger, and S. R. Carding. 1992. Roles of αβ and γδ T cell subsets in viral immunity. Annu. Rev. Immunol. 10:123-151.
8. Ezekowitz, R. A. B., K. N. Sastry, and K. B. M. Reid (ed.). 1996. Collectins and innate immunity. R. G. Landes Company, Austin, Tex.
9. Hartley, C. A., P. C. Reading, A. C. Ward, and E. M. Anders. 1997. Changes in the hemagglutinin molecule of influenza A (H3N2) virus associated with increased virulence for mice. Arch. Virol. 142:75-88.
10. Hartshorn, K. L., E. C. Crouch, M. R. White, P. Eggleton, A. I. Tauber, D. Chang, and K. Sastry. 1994. Evidence for a protective role of pulmonary surfactant protein D (SP-D) against influenza A viruses. J. Clin. Invest. 94:311-319.
11. Hartshorn, K. L., and A. I. Tauber. 1988. The influenza virus-infected phagocyte. A model of deactivation. Hematol. Oncol. Clin. N. Am. 2:301-315.
12. Holmskov, U., R. Malhotra, R. B. Sim, and J. Jensenius. 1994. Collectins: collagenous C-type lectins of the innate immune defense system. Immunol. Today 15:67-74.
13. Hoppe, H.-J., and K. B. M. Reid. 1994. Collectins - soluble proteins containing collagenous regions and lectin domains - and their role in innate immunity. Protein Sci. 3:1143-1158.
14. Kilbourne, E. D. 1969. Future influenza vaccines and the use of genetic recombinants. Bull. W. H. O. 41:643-645.
15. Koziel, H., and M. J. Koziel. 1995. Pulmonary complications of diabetes mellitus: pneumonia. Infect. Dis. Clin. N. Am. 9:65-95.
16. Kuan, S.-F., K. Rust, and E. Crouch. 1992. Interactions of surfactant protein D with bacterial lipopolysaccharides. Surfactant protein D is an Escherichia coli-binding protein in bronchoalveolar lavage. J. Clin. Invest. 90:97-106.
17. Lim, B.-L., J.-Y. Wang, U. Holmskov, H.-J. Hoppe, and K. B. M. Reid. 1994. Expression of the carbohydrate recognition domain of lung surfactant protein D and demonstration of its binding to lipopolysaccharides of gram-negative bacteria. Biochem. Biophys. Res. Commun. 202:1674-1680.
18. Mackowiack, P. A., R. M. Martin, S. R. Jones, and J. W. Smith. 1978. Pharyngeal colonization by Gram-negative bacilli in aspiration-prone persons. Arch. Intern. Med. 138:1224-1227.
19. Persson, A., D. Chang, and E. Crouch. 1990. Surfactant protein D (SP-D) is a divalent cation-dependent carbohydrate-binding protein. J. Biol. Chem. 265:5755-5760.
20. Reading, P. C., L. S. Morey, E. C. Crouch, and E. M. Anders. 1997. Collectin-mediated antiviral host defense of the lung: evidence from influenza virus infection of mice. J. Virol. 71:8204-8212.
21. Schelenz, S., R. Malhotra, R. B. Sim, U. Holmskov, and G. J. Bancroft. 1995. Binding of host collectins to the pathogenic yeast Cryptococcus neoformans: human surfactant protein D acts as an agglutinin for acapsular yeast cells. Infect. Immun. 63:3360-3366.